Addressing Metabolic Dysfunction‑Associated Steatotic Liver Disease (MASLD) in Endocrinology Settings in Canada: From Prevalence to Patient-Centered Management. Can Diabetes Endocrinol Today 2025, 3 (s01), 2–8. https://doi.org/10.58931/cdet.2025.3s0144.